drugset / Trial / NCT01743976
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Phase 4
Terminated
5 enrolled
Wake Forest University
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Based on laboratory studies, donepezil will improve pain relief more than placebo in patients with chronic neuropathic pain who are currently taking gabapentin or pregabalin.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-10-23
- Completion
- 2013-10-23
Outcome
Outcome not reported
Stopped (Enrollment): “Failure to recruit subjects”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | — |